Brief: Reneo Pharmaceuticals Says First Patient Has Been Dosed In Stride Study
28/07/2021 13:23
July 28 (Reuters) - Reneo Pharmaceuticals Inc RPHM.O :
* RENEO PHARMACEUTICALS - FIRST PATIENT HAS BEEN DOSED IN
STRIDE
STUDY
Source text for Eikon: ID:nGNX7Wjz70
Further company coverage: RPHM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Onkure Therapeutics
See all newsBrief: Onkure Therapeutics Inc Files For Mixed Shelf Of Up To $200 Million - SEC Filing
Onkure Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Onkure Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Onkure Therapeutics Inc expected to post a loss of $1.46 a share - Earnings Preview
U.S. RESEARCH ROUNDUP-F5, Nextracker, Stryker